All Stories

  1. Model for prediction of MRP-2 inhibition
  2. HToPred: A Tool for Human Topoisomerase II Inhibitor Prediction
  3. Characterization of forced degradation products of canagliflozine by liquid chromatography/quadrupole time-of-flight tandem mass spectrometry and in silico toxicity predictions
  4. Identification and characterization of vilazodone metabolites in rats and microsomes by ultrahigh-performance liquid chromatography/quadrupole time-of-flight tandem mass spectrometry
  5. Identification and characterization of fluvastatin metabolites in rats by UHPLC/Q-TOF/MS/MS and in silico toxicological screening of the metabolites
  6. Biological Evaluation of Small Molecule Inhibitors of Mtb-ASADH Enzyme
  7. An improved approach for predicting drug–target interaction: proteochemometrics to molecular docking
  8. Liquid Chromatographic Method Development for Forced Degradation Products of Dabigatran Etexilate: Characterisation and In Silico Toxicity Evaluation
  9. Computational Approaches for Enzyme Functional Class Prediction: A Review
  10. Rapid structural characterization ofin vivoandin vitrometabolites of tinoridine using UHPLC-QTOF-MS/MS andin silicotoxicological screening of its metabolites
  11. Classification of Breast Cancer Resistant Protein (BCRP) Inhibitors and Non-Inhibitors Using Machine Learning Approaches
  12. Characterization of forced degradation products of pazopanib hydrochloride by UHPLC-Q-TOF/MS andin silicotoxicity prediction
  13. Molecular Mechanism of Poly(vinyl alcohol) Mediated Prevention of Aggregation and Stabilization of Insulin in Nanoparticles
  14. Pharmacoinformatics analysis to identify inhibitors ofMtb-ASADH
  15. Characterization of stress degradation products of mirabegron using UPLC-QTOF-MS/MS and in silico toxicity predictions of its degradation products
  16. Characterization of stress degradation products of blonanserin by UPLC-QTOF-tandem mass spectrometry
  17. Role of breast cancer resistance protein (BCRP) as active efflux transporter on blood-brain barrier (BBB) permeability
  18. Development of [ 18 F]-Labeled Pyrazolo[4,3- e ]-1,2,4- triazolo[1,5- c ]pyrimidine (SCH442416) Analogs for the Imaging of Cerebral Adenosine A 2A Receptors with Positron Emission Tomography
  19. Computational Approaches for Enzyme Functional Class Prediction: A Review
  20. A comparative study of integrase-binding domain of homologous HRP2 and LEDGF/p75 protein: from sequence to structural characterisation
  21. Shape-based virtual screening, docking, and molecular dynamics simulations to identifyMtb-ASADH inhibitors
  22. Insights into controlling role of substitution mutation, E315G on thermostability of a lipase cloned from metagenome of hot spring soil
  23. Molecular Modeling and Active Site Binding Mode Characterization of Aspartate β-Semialdehyde Dehydrogenase Family
  24. QSAR Study of Curcumine Derivatives as HIV-1 Integrase Inhibitors
  25. In silico screening for identification of novel HIV-1 integrase inhibitors using QSAR and docking methodologies
  26. QSAR Study of Curcumine Derivatives as HIV-1 Integrase Inhibitors
  27. High-throughput virtual screening of phloroglucinol derivatives against HIV-reverse transcriptase
  28. Cystathionineβ-Lyase-Like Protein with Pyridoxal Binding Domain Characterized inLeishmania majorby Comparative Sequence Analysis and Homology Modelling
  29. Identification of Novel HIV-1 Integrase Inhibitors Using Shape-Based Screening, QSAR, and Docking Approach
  30. Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and docking analysis
  31. Comparative docking and CoMFA analysis of curcumine derivatives as HIV-1 integrase inhibitors
  32. Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5
  33. Active site binding interactions of β-carboline derivative for HIV reverse transcriptase, protease and integrase
  34. Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase
  35. Synthesis and Antileishmanial activity of Piperoyl-Amino Acid Conjugates
  36. Docking-based 3D-QSAR study of HIV-1 integrase inhibitors
  37. 3D-QSAR studies of substituted 1-(3, 3-diphenylpropyl)-piperidinyl amides and ureas as CCR5 receptor antagonists
  38. In Silico Prediction of Blood Brain Barrier Permeability:  An Artificial Neural Network Model
  39. In Silico Modeling for Blood—Brain Barrier Permeability Predictions